# Prevention of Gastric Ulcers

> **NCT00629512** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 504 (estimated)

## Conditions studied

- NSAID Associated Gastric Ulcers

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Esomeprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00629512
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2002-12
- **Final completion:** 2002-12
- **Target enrollment:** 504 (ESTIMATED)
- **Last updated:** 2009-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00629512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00629512, "Prevention of Gastric Ulcers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00629512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*